When you participate in a medically supervised program, you arent just getting a prescription
Patients who dont lose significant weight may see less improvement
The realistic timeline Based on the current state of the clinical program, regulatory precedent, and publicly available information from Eli Lilly, here is the most realistic projection: Mid to late 2026: Remaining TRIUMPH, TRANSCEND, and SYNERGY Phase 3 results are reported
Average weight loss at 3 months ranges from 5 to 12 pounds, depending on your starting dose, adherence, diet, and activity level
Studies have shown that PT-141 selectively stimulates solicitational behaviors in female rats, which are analogous to sexual arousal in humans, without affecting other sexual behaviors such as lordosis or pacing